Using the PDPS platform in joint research with MSD, a milestone was achieved and a milestone fee was received. Impact on earnings guidance is unchanged at this time and not disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4587","jir_company_name":"PeptiDream Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-07","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4587-20261007-01.pdf","jir_short_summary":"Using the PDPS platform in joint research with MSD, a milestone was achieved and a milestone fee was received. Impact on earnings guidance is unchanged at this time and not disclosed.","jir_summary":"### Summary of the News\nPeptiDream Inc. has achieved a significant milestone in the PCC program under joint research and development with MSD and has received a milestone fee. This result demonstrates the utility and versatility of the PDPS platform, and PeptiDream Inc. will continue close collaboration with MSD to advance the program. The amount related to this milestone has not been disclosed.\n\n### Impact on Business and Financials\nThis announcement concerns a contract-based milestone fee and has already been factored into the full-year earnings forecast for the fiscal year ending December 2026; there is no change to the current earnings forecast. If any changes to the earnings forecast occur, they will be disclosed promptly.","jir_financial_highlights":"Milestone fee: Unknown (Unknown)\nImpact on earnings guidance: Unknown (Already factored in (Fiscal year ending December 2026 forecast))","jir_category":"","jir_hashtags":"#PeptiDream (company-specific tags omitted)","jir_key_figures":"Milestone fee: Unknown\nEarnings forecast for fiscal year ending December 2026: Already factored in, unchanged\nJoint research with MSD: PCC program, PDPS technology","jir_meta_title":"PeptiDream Inc. Announces Milestone Achievement in Joint Research with MSD | Fiscal Year Ending December 2026","jir_meta_description":"PeptiDream Inc. announced it achieved a milestone in joint research with MSD and received a milestone fee. The fee has been factored into earnings guidance and there is no change to forecasts. Watch for future progress.","jir_og_title":"PeptiDream Inc. Announces Milestone Achievement in Joint Research with MSD","jir_og_description":"PeptiDream Inc. achieved a milestone in joint research with MSD and received a milestone fee. There is no impact on earnings guidance. Anticipation for future developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8926,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-128146","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n